Carisma Therapeutics Financial Overview
Carisma Therapeutics's market cap is currently $2.22M. The company's EPS TTM is $-0.23; its P/E ratio is 0.28; Carisma Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
